CHICAGO (Reuters) - Doctors should prescribe the lowest doses of Celebrex possible in patients at high risk of heart problems, researchers who did a combined analysis of six studies of the Pfizer Inc ...
With concern growing that a popular new class of arthritis medicine might increase a patient's risk of heart attack and stroke, the maker of Celebrex -- one of the most widely sold drugs in the world ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback